Evaluation of a novel ELISA screening test for detection of factor VIII inhibitory antibodies in haemophiliacs
- 1 March 1999
- journal article
- research article
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 21 (2) , 125-128
- https://doi.org/10.1046/j.1365-2257.1999.00194.x
Abstract
Treatment of patients with haemophilia A with coagulation factor concentrates may result in the development of inhibitory antibodies directed against factor VIII (FVIII). In this study, a previously ...Keywords
This publication has 11 references indexed in Scilit:
- High incidence of anti‐FVIII antibodies against non‐coagulant epitopes in haemophilia A patients: a possible role for the half‐life of transfused FVIIIBritish Journal of Haematology, 1996
- Recommendations for the treatment of factor VIII inhibitorsBlood Coagulation & Fibrinolysis, 1996
- The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and ReliabilityThrombosis and Haemostasis, 1995
- Quantitation of factor VIII antibodies by an enzyme-linked immunoassay method [letter]Blood, 1994
- Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIThe Lancet, 1993
- Complications of Hemophilia A Treatment: Factor VIII InhibitorsaAnnals of the New York Academy of Sciences, 1991
- A Comparison of the Bethesda and New Oxford Methods of Factor VIII Antibody AssayThrombosis and Haemostasis, 1982
- A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIIIThrombosis and Haemostasis, 1981